Frequently Asked Questions
North America dominates the cell line development market owing to the rising prevalence of presence of major research and academic institutes as well as biopharmaceutical companies and favourable reimbursement scenario in this region.
The growth rate of the cell line development market is 12.14%.
Upsurge in the production of vaccines globally especially post the spread of coronavirus & Rising adoption of advanced healthcare technologies coupled with increasing incidences of cancer are the growth drivers of the cell line development market.
Product, source, cell line type and application are the factors on which the cell line development market research is based.
Major companies in the cell line development market are Eurofins Scientific, GENERAL ELECTRIC COMPANY, Lonza, F. Hoffmann-La Roche Ltd, Abbott, bioMérieux SA, Thermo Fischer Scientific, Inc., Bio-Rad Laboratories. Inc, Danaher, Promega Corporation, Merck KGaA, Sartorius AG, Corning Incorporated, Cytovance Biologics, JSR Life Sciences, LLC, trenzyme GmbH, MabPlex International Ltd., GenScript, Charles River Laboratories and Abzena Ltd.
